Can-Fite Biopharma Ltd ADR (NY: CANF )
2.300
-0.040
(-1.71%)
Streaming Delayed Price
Updated: 11:55 AM EDT, Aug 21, 2024
Add to My Watchlist
All News about Can-Fite Biopharma Ltd ADR![]() ![]() ![]() ![]()
Can Fite Biofarma: Q4 Earnings Insights
March 28, 2024
Via Benzinga
![]()
Recap: Can Fite Biofarma Q3 Earnings
November 30, 2023
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
Can-Fite Reports 2023 Financial Results and Clinical Update
March 28, 2024
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
December 18, 2023
Via Business Wire
![]() ![]() Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Can-Fite Biopharma Ltd ADR (NY: CANF )
2.300
-0.040
(-1.71%)
Streaming Delayed Price
Updated: 11:55 AM EDT, Aug 21, 2024
Add to My Watchlist
All News about Can-Fite Biopharma Ltd ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|